From DCAT Value Chain Insights (VCI)
Dr. Ulrich Küsthardt was named the new chief innovation officer at Evonik, beginning January 1, 2015. Dr. Küsthardt, who succeeds Dr. Peter Nagler, plans to continue strengthening the company’s innovation capacity, continuing his predecessor’s work.
Küsthardt, who holds a doctorate in chemistry, began his career at an international consulting firm. Starting in 1997, he held positions at a predecessor of Evonik, initially in controlling as well as in marketing and sales. He later went on to manage various business units, heading up the Coatings & Additives Business Unit of Evonik Industries from 2008.
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription